Notice of Intent To Grant a Partially Exclusive Patent License

Published date09 June 2020
Citation85 FR 35293
Record Number2020-12387
SectionNotices
CourtAir Force Department,Defense Department
Federal Register, Volume 85 Issue 111 (Tuesday, June 9, 2020)
[Federal Register Volume 85, Number 111 (Tuesday, June 9, 2020)]
                [Notices]
                [Page 35293]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-12387]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF DEFENSE
                Department of the Air Force
                Notice of Intent To Grant a Partially Exclusive Patent License
                AGENCY: Department of the Air Force, Department of Defense.
                ACTION: Notice of intent.
                -----------------------------------------------------------------------
                SUMMARY: Pursuant to the Bayh-Dole Act and implementing regulations,
                the United States Air Force (Air Force) is issuing this notice of
                intent to grant a partially exclusive patent license agreement with
                respect to the field of remote care management of patients with
                autoimmune disease (which are conditions caused by increased reactivity
                of the immune system causing tissue damage) to Adyptation Inc., a C-
                Corporation duly organized, validly existing, and in good standing in
                the State of Delaware, having a place of business at 3040 South Tech
                Blvd., Miamisburg, OHIO.
                DATES: Written objections must be filed no later than fifteen (15)
                calendar days after the date of publication of this Notice.
                ADDRESSES: Submit written objections to the Air Force Materiel Command
                Law Office, AFMCLO/JAZ, 2240 B Street, Room 260, Wright-Patterson AFB,
                OH 45433-7109; Facsimile: (937) 255-3733; or Email:
                [email protected]. Include Docket No. ARH-200504A-PL in the
                subject line of the message.
                FOR FURTHER INFORMATION CONTACT: Air Force Materiel Command Law Office,
                AFMCLO/JAZ, 2240 B Street, Rm 260, Wright-Patterson AFB, OH 45433-7109;
                Facsimile: (937) 255-3733; Email: [email protected].
                SUPPLEMENTARY INFORMATION: The Department of the Air Force intends to
                grant the partially exclusive patent license agreement for the
                invention described in: U.S. Patent No. 8,568,145, entitled,
                ``Predictive Performance Optimizer,'' filed August 19, 2011, and issued
                October 29, 2013; and U.S. Patent No. 8,777,628, entitled, ``Predictive
                Performance Optimizer,'' filed April 1, 2013, and issued July 15, 2014.
                 The Department of the Air Force may grant the prospective license
                unless a timely objection is received that sufficiently shows the grant
                of the license would be inconsistent with the Bayh-Dole Act or
                implementing regulations. A competing application for a patent license
                agreement, completed in compliance with 37 CFR 404.8 and received by
                the Air Force within the period for timely objections, will be treated
                as an objection and may be considered as an alternative to the proposed
                license.
                 Authority: 35 U.S.C. 209; 37 CFR 404.
                Adriane Paris,
                Acting Air Force Federal Register Liaison Officer.
                [FR Doc. 2020-12387 Filed 6-8-20; 8:45 am]
                 BILLING CODE 5001-10-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT